Dysport Therapeutic (abobotulinumtoxina)

pCPA File Number: 21045

Negotiation Status:

Concluded with an LOI

Indication(s):

Cervical dystonia

Sponsor/Manufacturer:

Ipsen Biopharmaceuticals Canada, Inc.

CDA-AMC Project Number:

SR0512-000

pCPA Engagement Letter Issued:

2018-05-04

Negotiation Process Concluded:

2018-07-17